Verastem Inc (VSTM) Inventory Turnover Ratio, from first quarter 2026 to first quarter 2025, current and historic results, rankings and more, Quarterly Fundamentals - CSIMarket
CSIMarket Company Name, Ticker, Suppliers, else..
 
Verastem Inc   (NASDAQ: VSTM)
 

Verastem Inc Inventory Turnover Ratio (COS)

Cost of Sales Formula, Quarterly Results, Trends, Rankings, Statistics

Due to inventory build up in the first quarter 2026, Verastem Inc 's inventory turnover ratio sequentially decreased to 0.55 in the first quarter 2026, unsurprisingly, as the Verastem Inc markets continue to deteriorate, and VSTM's faces growing challenges to bring down its inventories. Verastem Inc 's average inventory processing period in the Mar 31 2026 quarter, has increased to 664 days, from 629 days, in the Dec 31 2025 quarter.

Within Healthcare sector 349 other companies have achieved higher inventory turnover ratio. While in terms of ranking among all other companies, the company has moved form 0 in the fourth quarter 2025, to 1659.

VSTM Inventory Turnover Ratio using Sales Formula
What is Inventory Turnover Ratio?
What is Verastem Inc Market Share?

What is Inventory Turnover Ratio?



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

VSTM Inventory Turnover Ratio (Mar 31 2026)
I. Quarter		 (Dec 31 2025)
IV. Quarter		 (Sep 30 2025)
III. Quarter		 (Jun 30 2025)
II. Quarter		 (Mar 31 2025)
I. Quarter
Y / Y Inventory Growth - - - - -
Y / Y Cost of Sales Growth - - - - -
Inventory Turnover Ratio (TTM) 0.55 0.58 0.56 0.44 -
VSTM's Total Ranking # 1659 # 0 # 0 # 0 # 0
Average inventory processing period 661 627 647 833 -
Seq. Inventory Growth 24.77 % 2.17 % 53.6 % - -
Seq. Cost of Sales Growth -0.36 % -3.45 % 126.56 % - -




Inventory Turnover Ratio Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 109
Healthcare Sector # 350
Overall Market # 1659

Inventory Turnover Ratio Statistics
High Average Low
3.8 1.76 0.44
(Sep 30 2019)   (Jun 30 2020)



VSTM Company Profile >> Back to VSTM Efficiency Comparisons >> Compare VSTM Inventory Turnover Ratio to its Competitors

Financial Statements
Verastem Inc 's Inventories $ 2 Millions Visit VSTM's Balance sheet
Verastem Inc 's Cost of Revenues TTM $ 1 Millions Visit VSTM's Income Statement
What are VSTM's Sales? Visit VSTM's Sales by Segment

Other Inventory Turnover Ratios
Verastem Inc 's Inventory to Sales Ratio
U.S. Durable Goods Inventory to Shipment Ratio By Product
Major Pharmaceutical Preparations Industry Inventory Turnover Trends and Statistics
Healthcare Sector Inventory Turnover Statistics
Inventory Turnover Trends for overall market
VSTM's Inventory Turnover Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Inventory Turnover
Lowest Ranking Inventory Turnover
Inventory Turnover for VSTM's Competitors
Inventory Turnover Ratio for VSTM's Suppliers
Inventory Turnover Ratio for VSTM's Customers

You may also want to know
VSTM's Sales Growth Rates VSTM's Pe Price to earnings ratio VSTM's Receivables Turnover Ratio VSTM's Stock Quote
VSTM's Net Income Growth Rates VSTM's Ps Price to Sales ratio VSTM's Sales per Employee VSTM's Asset Turnover Ratio
VSTM's Net Margin VSTM's Pb Price to Book ratio VSTM's Financial Strength Ratios VSTM's Dividend Payout Ratio



Companies with similar Inventory Turnover Ratio for the quarter ending Mar 31 2026, within Healthcare Sector Inventory Turnover Ratio Cost of revenues at quarter ending Mar 31 2026 Inventories at quarter ending Mar 31 2026
Assertio Holdings inc   1.16 $ 30.308  Millions$ 26  Millions
Beone Medicines Ltd   1.15 $ 670.000  Millions$ 581  Millions
Biogen Inc   1.13 $ 2,435.900  Millions$ 2,150  Millions
Bridgebio Pharma Inc   1.10 $ 28.262  Millions$ 26  Millions
60 Degrees Pharmaceuticals Inc   1.10 $ 0.794  Millions$ 1  Millions
Penumbra Inc  1.10 $ 474.318  Millions$ 433  Millions
Keenova Therapeutics Plc  1.09 $ 815.400  Millions$ 749  Millions
Zoetis Inc   1.09 $ 2,685.000  Millions$ 2,471  Millions
Treace Medical Concepts Inc   1.08 $ 42.052  Millions$ 39  Millions
Corcept Therapeutics Inc  1.07 $ 13.457  Millions$ 13  Millions
Zimmer Biomet Holdings Inc   1.06 $ 2,520.100  Millions$ 2,368  Millions
Acadia Pharmaceuticals Inc   1.06 $ 93.397  Millions$ 88  Millions
Vertex Pharmaceuticals Inc  1.02 $ 1,681.100  Millions$ 1,645  Millions
Sensus Healthcare Inc   1.02 $ 14.403  Millions$ 14  Millions
Blue Water Vaccines Inc  1.01 $ 0.150  Millions$ 0  Millions
Pacira Biosciences inc   1.00 $ 151.856  Millions$ 152  Millions
Profound Medical Corp   1.00 $ 5.442  Millions$ 5  Millions
Hyperfine Inc   0.99 $ 6.000  Millions$ 6  Millions
Petvivo Holdings Inc   0.99 $ 0.486  Millions$ 0  Millions
Ionis Pharmaceuticals Inc   0.97 $ 8.597  Millions$ 9  Millions
Rhythm Pharmaceuticals Inc   0.96 $ 23.001  Millions$ 24  Millions
Eli Lilly And Company  0.96 $ 12,404.800  Millions$ 12,867  Millions
Rxsight Inc   0.96 $ 29.000  Millions$ 30  Millions
Adma Biologics Inc   0.96 $ 195.347  Millions$ 204  Millions
Protalix Biotherapeutics inc   0.93 $ 22.940  Millions$ 25  Millions
Alkermes Plc   0.91 $ 208.838  Millions$ 229  Millions
Emergent Biosolutions Inc   0.91 $ 309.700  Millions$ 341  Millions
Inspire Medical Systems inc   0.90 $ 130.000  Millions$ 144  Millions
Seer Inc   0.89 $ 7.000  Millions$ 8  Millions
Abeona Therapeutics Inc   0.89 $ 4.228  Millions$ 5  Millions

Date modified: 2026-08-30T14:48:48+00:00




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.